Introduction: Reliable estimation of left ventricular (LV) parameters with the use of computed tomography (CT) has not been verified in patients with low ejection fraction (EF) so far.
Objectives: The aim of this preliminary study was to assess the agreement between magnetic resonance imaging (MRI) and CT in the assessment of the LV volume and EF in patients with low EF scheduled for coronary artery bypass grafting (CABG).
Patients And Methods: In 18 patients (2 women, 16 men) with the EF of 40% or lower scheduled for CABG, cardiac 1.5T MRI and 16‑slice CT were performed within 48 hours before surgery. All MRI scans were analyzable; 5 CT exams were excluded due to poor quality. Between‑method agreement was assessed using the analysis of correlation and the Bland‑Altman plots.
Results: The end‑systolic volume (ESV), end‑diastolic volume (EDV), and stroke volume (SV) were higher when measured by MRI compared with CT (P <0.05 for all). The EF values measured by both methods were comparable. We observed a strong positive correlation between MRI and CT in the measurement of ESV (R = 0.86), EDV (R = 0.71), and EF (R = 0.68), but there was no correlation for SV (R = 0.07). The Bland‑Altman analysis confirmed that the LV volumes assessed by MRI were higher compared with those determined by CT. There was also a trend for larger differences between the 2 methods in the measurement of ESV and EDV. The EF value was higher on MRI compared with CT but the difference was nonsignifiact.
Conclusions: In patients with coronary artery disease and low EF, the EF values measured by MRI and CT are comparable, but the ESV, EDV, and SV parameters cannot be used interchangeably due to their underestimation on CT.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.20452/pamw.1373 | DOI Listing |
Cancer Cytopathol
February 2025
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Background: Major mutations (e.g., KRAS, GNAS, TP53, SMAD4) in pancreatic cyst fluid (PCF) are useful for classifying and risk stratifying certain cyst types, particularly in cases with nondiagnostic cytology.
View Article and Find Full Text PDFCancer Med
February 2025
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Introduction: Immune checkpoint inhibitors (ICI) have improved the therapeutic arsenal in outpatient oncology care; however, data on necessity of hospitalizations associated with immune-related adverse events (irAEs) are scarce. Here, we characterized hospitalizations of patients undergoing ICI, from the prospective cohort study of the immune cooperative oncology group (ICOG) Hannover.
Methods: Between 12/2019 and 06/2022, 237 patients were included.
Clin Transl Allergy
January 2025
University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Department of Chest Diseases, Istanbul, Turkey.
Background: Asthma is one of the most common causes of chronic respiratory disease, and countries with low socioeconomic status have both a high prevalence of asthma and asthma-related death.
Objective: In this study, we aimed to determine socioeconomic levels of asthmatic patients according to a national database and investigate the effects of social markers on disease control in our region.
Methods: This is an analysis of data from 2053 adult asthma patients from a multicentre chart study in Turkey.
Lipids
January 2025
Department of Laboratory Medicine, Peoples Hospital of Deyang City, Deyang, China.
Lipid-lowering drugs have been used in clinics widely. It is unclear whether the drugs have an effect on renal failure. We chose high-density lipoprotein cholesterol (ieu-b-109), low-density lipoprotein cholesterol (ieu-a-300), triglyceride (ieu-b-111), and total cholesterol (ebi-a-GCST90038690) as exposures.
View Article and Find Full Text PDFCancer
February 2025
Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer, Houston, Texas, USA.
Background: There is much concern that opioids administered as intravenous (iv) bolus for pain relief may inadvertently increase their risk for abuse. However, there is insufficient data to support this. The authors compared the abuse liability potential, analgesic efficacy, and adverse effect profile of fast (iv push) versus slow (iv piggyback) administration of iv hydromorphone among hospitalized patients requiring iv opioids for pain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!